Reduction in MRSA environmental contamination with a portable HEPA-filtration unit

Summary

There is renewed interest in the hospital environment as a potentially important factor for cross-infection with methicillin-resistant Staphylococcus aureus (MRSA) and other nosocomial pathogens. The aim of this study was to evaluate the effectiveness of a portable high-efficiency particulate air (HEPA)-filtration unit (IQAir Cleanroom H13, Incen AG, Goldach, Switzerland) at reducing MRSA environmental surface contamination within a clinical setting. The MRSA contamination rate on horizontal surfaces was assessed with agar settle plates in ward side-rooms of three patients who were heavy MRSA dispersers. Contamination rates were measured at different air filtration rates (60–235 m³/h) and compared with no air filtration using Poisson regression. Without air filtration, between 80% and 100% of settle plates were positive for MRSA, with the mean number of MRSA colony-forming units (cfu)/10-h exposure/plate ranging from 4.1 to 27.7. Air filtration at a rate of 140 m³/h (one patient) and 235 m³/h (two patients), resulted in a highly significant decrease in contamination rates compared with no air filtration (adjusted rate ratios 0.037, 0.099 and 0.248, respectively; P < 0.001 for each). A strong association was demonstrated between the rate of air filtration and the mean number of MRSA cfu/10-h exposure/plate (P for trend < 0.001). In conclusion, this portable HEPA-filtration unit can significantly reduce MRSA environmental contamination within patient isolation rooms, and this may prove to be a useful addition to existing MRSA infection control measures.

Introduction

Handwashing by healthcare workers is thought to be the most important method of control of methicillin-resistant Staphylococcus aureus (MRSA) and other nosocomial infections.¹ However, there is renewed interest in the hospital environment as a potentially important factor in cross-infection.2, 3, 4 The authors recently investigated an outbreak of Hickman-line-associated MRSA bacteraemia in a haematology day-case unit. As part of the investigations, significant MRSA contamination of the environment was found, and settle plates were positive for MRSA on a number of occasions, suggesting ongoing dispersal of MRSA into the air. At least two patients were identified as heavy shedders of MRSA, and the outbreak was controlled when a single room was designated for their further day-case treatment.

This outbreak prompted an investigation of technologies that may reduce future MRSA environmental contamination within such a setting. A number of air decontamination products have been reviewed recently by the Rapid Review Panel of the Health Protection Agency, including air filtration units and ultra-violet air disinfection units (www.hpa.org.uk/infections/topics_az/rapid_review). Two of these products have been recommended for in-use evaluations in a clinical setting (recommendation level 2), including the IQAir Cleanroom H13 portable air purification unit (Incen AG, Goldach, Switzerland). This article presents an evaluation of the effectiveness of the IQAir unit at preventing contamination of environmental surfaces with MRSA in three different clinical settings.